GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3551 - 3575** of **4050** in total

« First

‹ Prev

…

139

140

141

142

143

144

145

146

147

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	15	mild	G09609EN	91
IgG	Patient 2	24	mild	G09609EN	107
IgM	Patient 2	15	mild	G09609EN	341
IgM	Patient 2	24	mild	G09609EN	425
IgM	Patient 1	6	moderate	G09609EN	52
IgA	Patient 2	3	mild	G09609EN	986
IgG	Patient 2	3	mild	G09609EN	127
IgM	Patient 2	3	mild	G09609EN	547
IgA	Patient 3	-180	mild	G09609EN	250
IgA	Patient 3	11	mild	G09609EN	422
IgG	Patient 3	-180	mild	G09609EN	44
IgG	Patient 3	11	mild	G09609EN	43
IgM	Patient 3	-180	mild	G09609EN	84
IgA	Patient 3	4	mild	G09609EN	457
IgG	Patient 3	4	mild	G09609EN	44
IgM	Patient 3	11	mild	G09609EN	178
IgM	Patient 3	4	mild	G09609EN	160
IgA	Patient 4	12	mild	G09609EN	380
IgG	Patient 4	12	mild	G09609EN	54
IgM	Patient 4	12	mild	G09609EN	117
IgA	Patient 1	10	moderate	G09482NW	423
IgA	Patient 1	22	moderate	G09482NW	381
IgA	Patient 1	6	moderate	G09482NW	387
IgG	Patient 1	10	moderate	G09482NW	33
IgG	Patient 1	22	moderate	G09482NW	45